143 related articles for article (PubMed ID: 30718772)
1. A transcription factor PU.1 is critical for Ccl22 gene expression in dendritic cells and macrophages.
Yashiro T; Nakano S; Nomura K; Uchida Y; Kasakura K; Nishiyama C
Sci Rep; 2019 Feb; 9(1):1161. PubMed ID: 30718772
[TBL] [Abstract][Full Text] [Related]
2. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
3. Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells.
Miura R; Kasakura K; Nakano N; Hara M; Maeda K; Okumura K; Ogawa H; Yashiro T; Nishiyama C
PLoS One; 2016; 11(4):e0154094. PubMed ID: 27105023
[TBL] [Abstract][Full Text] [Related]
4. Critical Role of Transcription Factor PU.1 in the Function of the OX40L/TNFSF4 Promoter in Dendritic Cells.
Yashiro T; Hara M; Ogawa H; Okumura K; Nishiyama C
Sci Rep; 2016 Oct; 6():34825. PubMed ID: 27708417
[TBL] [Abstract][Full Text] [Related]
5. PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.
Yashiro T; Kubo M; Ogawa H; Okumura K; Nishiyama C
PLoS One; 2015; 10(9):e0137699. PubMed ID: 26361334
[TBL] [Abstract][Full Text] [Related]
6. PU.1 and IRF8 Modulate Activation of NLRP3 Inflammasome
Yashiro T; Yamamoto M; Araumi S; Hara M; Yogo K; Uchida K; Kasakura K; Nishiyama C
Front Immunol; 2021; 12():649572. PubMed ID: 33897697
[TBL] [Abstract][Full Text] [Related]
7. The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2.
Yashiro T; Yamaguchi M; Watanuki Y; Kasakura K; Nishiyama C
J Immunol; 2018 Dec; 201(12):3677-3682. PubMed ID: 30413670
[TBL] [Abstract][Full Text] [Related]
8. The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c.
Yashiro T; Kasakura K; Oda Y; Kitamura N; Inoue A; Nakamura S; Yokoyama H; Fukuyama K; Hara M; Ogawa H; Okumura K; Nishiyama M; Nishiyama C
Int Immunol; 2017 Feb; 29(2):87-94. PubMed ID: 28338898
[TBL] [Abstract][Full Text] [Related]
9. PU.1 plays a pivotal role in dendritic cell migration from the periphery to secondary lymphoid organs
Yashiro T; Takeuchi H; Nakamura S; Tanabe A; Hara M; Uchida K; Okumura K; Kasakura K; Nishiyama C
FASEB J; 2019 Oct; 33(10):11481-11491. PubMed ID: 31314592
[TBL] [Abstract][Full Text] [Related]
10. Dual Roles of PU.1 in the Expression of PD-L2: Direct Transactivation with IRF4 and Indirect Epigenetic Regulation.
Inaba K; Yashiro T; Hiroki I; Watanabe R; Kasakura K; Nishiyama C
J Immunol; 2020 Aug; 205(3):822-829. PubMed ID: 32611724
[TBL] [Abstract][Full Text] [Related]
11. Involvement of PU.1 in the transcriptional regulation of TNF-alpha.
Fukai T; Nishiyama C; Kanada S; Nakano N; Hara M; Tokura T; Ikeda S; Ogawa H; Okumura K
Biochem Biophys Res Commun; 2009 Oct; 388(1):102-6. PubMed ID: 19646961
[TBL] [Abstract][Full Text] [Related]
12. Critical role of transcription factor PU.1 in the expression of CD80 and CD86 on dendritic cells.
Kanada S; Nishiyama C; Nakano N; Suzuki R; Maeda K; Hara M; Kitamura N; Ogawa H; Okumura K
Blood; 2011 Feb; 117(7):2211-22. PubMed ID: 21119111
[TBL] [Abstract][Full Text] [Related]
13. Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells.
Hao S; Han X; Wang D; Yang Y; Li Q; Li X; Qiu CH
Immunology; 2016 Jun; 148(2):174-86. PubMed ID: 26868141
[TBL] [Abstract][Full Text] [Related]
14. Expression of macrophage-derived chemokine (CCL22) in atherosclerosis and regulation by histamine via the H2 receptor.
Kimura S; Tanimoto A; Wang KY; Shimajiri S; Guo X; Tasaki T; Yamada S; Sasaguri Y
Pathol Int; 2012 Oct; 62(10):675-83. PubMed ID: 23005594
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
[TBL] [Abstract][Full Text] [Related]
16. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.
Bakri Y; Sarrazin S; Mayer UP; Tillmanns S; Nerlov C; Boned A; Sieweke MH
Blood; 2005 Apr; 105(7):2707-16. PubMed ID: 15598817
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells.
Anderson KL; Perkin H; Surh CD; Venturini S; Maki RA; Torbett BE
J Immunol; 2000 Feb; 164(4):1855-61. PubMed ID: 10657634
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
Turner EC; Kinsella BT
J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF.
Ishii J; Kitazawa R; Mori K; McHugh KP; Morii E; Kondo T; Kitazawa S
J Cell Biochem; 2008 Oct; 105(3):896-904. PubMed ID: 18759249
[TBL] [Abstract][Full Text] [Related]
20. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
